About NR (Nicotinamide Riboside)
NR is a clinically validated oral NAD+ precursor that raises whole-blood NAD+ by 51% over 56 days at 600 mg daily. Enters cells via the NRK pathway, bypassing the NAMPT bottleneck.
Reported benefits
- Raises whole-blood NAD+ by 51% in 56 days
- Bypasses NAMPT enzyme bottleneck
- Oral capsule, GRAS-affirmed
Research citations
- Trammell et al. 2016 - Nature Communications
- Martens et al. 2018 - Nature Communications
How NR (Nicotinamide Riboside) fits the category
NR (Nicotinamide Riboside) sits inside the NAD+ Peptide Guide category. For the full ranking and head-to-head comparisons, read NAD+ Peptide Guide.